Taj Pharmaceuticals: Leading Manufacturer and Global Exporter of Potassium Iodate Tablets BP 170mg (TAJZOSAT)

Trusted Potassium Iodate Tablets BP 170mg Manufacturer in India

At Taj Pharmaceuticals, we pride ourselves on being one of the most reliable, reputed, and GMP-certified manufacturers of Potassium Iodate Tablets BP 170mg (TAJZOSAT) in Vapi, Gujarat, India. With decades of pharmaceutical expertise, we ensure the production of high-purity and high-quality potassium iodate tablets that adhere to BP (British Pharmacopoeia) standards.

These tablets are primarily used as a thyroid-blocking agent to protect against radioactive iodine exposure, typically administered in the event of nuclear accidents or emergencies. Our manufacturing process incorporates strict quality control protocols, resulting in stable iodine formulations that provide immediate and effective protection to the thyroid gland.

Why Potassium Iodate Tablets BP 170mg Are Crucial in Nuclear Safety

Potassium Iodate (KIO3) is a critical emergency pharmaceutical used to prevent the thyroid gland from absorbing radioactive iodine. Once ingested, potassium iodate saturates the thyroid with stable iodine, thereby blocking radioactive forms from entering. The protective effect of a single dose can last up to 24 hours, making it essential for repeated daily use until the radiation threat has passed.

At Taj Pharmaceuticals, we supply Potassium Iodate Tablets BP 170mg (TAJZOSAT) with guaranteed pharmaceutical-grade purity, enabling health authorities and emergency preparedness programs to act swiftly and confidently.

Potassium Iodate Tablets BP 170mg (TAJZOSAT) – Specifications and Composition

  • Brand Name: TAJZOSAT
  • Generic Name: Potassium Iodate BP
  • Strength: 170 mg
  • Form: Tablet
  • Usage: Thyroid protection during radioactive iodine exposure
  • Shelf Life: 36 months
  • Packaging: Blister or bottle packaging as per client requirement
  • Storage Conditions: Store in a dry, cool environment away from sunlight

We also offer custom labeling, export documentation, and regulatory support for international markets, including Africa, the Middle East, Latin America (LTAM), and Southeast Asia.

Uncompromised Quality from India’s Top GMP-Certified Manufacturer

Our WHO-GMP compliant facility in Vapi is outfitted with the latest technology and adheres to stringent international regulatory standards, including ISO, MHRA, and USFDA guidelines. Every batch of Potassium Iodate Tablets BP 170mg undergoes comprehensive analytical testing for:

  • Active Ingredient Assay
  • Impurity Profiling
  • Microbiological Testing
  • Stability Studies

This guarantees our customers the highest levels of consistency, reliability, and safety in every tablet.

Global Distribution and Export Leadership

Taj Pharmaceuticals is not just a domestic leader but also a pioneer exporter of Potassium Iodate Tablets across more than 80 countries. We are the preferred choice for government tenders, non-governmental organizations (NGOs), and disaster relief agencies around the globe.

We ensure on-time delivery and regulatory support, making us the top-rated Potassium Iodate Tablets BP 170mg supplier across:

  • Mumbai, Maharashtra
  • PAN India
  • Africa & Sub-Saharan regions
  • Middle East and GCC
  • LTAM and Southeast Asia

PCD Pharma Franchise and Contract Manufacturing Services

As part of our commitment to expanding pharmaceutical access, Taj Pharmaceuticals offers PCD pharma franchise opportunities and contract manufacturing services for Potassium Iodate Tablets BP 170mg. We provide:

  • Promotional Material Support
  • Third-Party Manufacturing Agreements
  • Exclusive Regional Franchise Rights
  • Competitive Pricing and Bulk Procurement Discounts

Whether you’re an established distributor or a new pharmaceutical entrepreneur, we empower your business with world-class formulations and manufacturing expertise.

Clinical Significance and Usage Guidelines

Potassium iodate is a prophylactic treatment used during radiation emergencies. It’s vital for individuals exposed to nuclear fallout to block radioactive iodine from accumulating in the thyroid gland, reducing the risk of thyroid cancer and other radiation-induced conditions.

Administration:

  • Dosage: As per local health authority recommendations
  • Timing: Ideally within 2 to 4 hours of exposure
  • Duration: Continue daily dosing until advised by health authorities

Note: Potassium iodate should not be used routinely and is not recommended for individuals with kidney disease, due to the risk of hyperkalemia (elevated potassium levels in the blood).

Advantages of Choosing TAJZOSAT from Taj Pharmaceuticals

  • ✅ Proven efficacy as a thyroid-blocking agent
  • ✅ Stringent compliance with international pharmacopeial standards
  • ✅ Reliable supply chain and global logistics support
  • ✅ Bulk order ready, with competitive pricing
  • ✅ Customized branding and white-labeling options
  • ✅ Full export documentation and registration dossier support

Client Testimonials and Global Trust

Our clients, ranging from public health departments to international emergency organizations, consistently endorse our Potassium Iodate Tablets BP 170mg for their reliability, quality, and affordability. This trust is a direct result of our uncompromising commitment to public health and global safety standards.

Get in Touch with Taj Pharmaceuticals Today

Whether you’re seeking a trusted manufacturer, global supplier, or PCD partner, Taj Pharmaceuticals is your one-stop solution for Potassium Iodate Tablets BP 170mg (TAJZOSAT). Our dedicated regulatory, logistics, and commercial teams ensure seamless service from order placement to delivery.

📍 Head Office: Vapi, Gujarat, India
📦 Dispatch Centers: Mumbai, Maharashtra & PAN India locations
🌍 Export Markets: Africa | Middle East | Southeast Asia | LATAM

Reach out to us for bulk procurement, international tenders, or franchise inquiries. We are committed to safeguarding global communities with our life-saving pharmaceutical solutions.